Statin bioavailability enhancement delivery composition
US8937081B2 · kind B2 · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 12, 2012 |
| Grant date | Jan 20, 2015 |
| Priority date | — |
| Expiry date | Dec 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for increasing the bioavailability of a statin active pharmaceutical ingredient (“API”) in humans and animals, wherein that composition includes a statin API selected from the group consisting of atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin, a first water soluble surfactant having a cloud point greater than about 37° C., a second water soluble surfactant having a cloud point greater than about 37° C., wherein a mixture of the first surfactant and the second surfactant comprises a cloud point less than about 37° C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.